Copy-number variations associated with neuropsychiatric conditions
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Neuropsychiatric conditions such as autism and schizophrenia have long been attributed to genetic alterations, but identifying the genes responsible has proved challenging. Microarray experiments have now revealed abundant copy-number variation--a type of variation in which stretches of DNA are duplicated, deleted and sometimes rearranged--in the human population. Genes affected by copy-number variation are good candidates for research into disease susceptibility. The complexity of neuropsychiatric genetics, however, dictates that assessment of the biomedical relevance of copy-number variants and the genes that they affect needs to be considered in an integrated context.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“microarray studies have revealed copy number variation (CNV) as risk factors 6”
From Functional impact of global rare copy number variation in autism spectrum disorders (2010) · cites this paper as [6]
In the citing paper
“Genes previously implicated in ASD by rare variant findings have pointed to functional themes in ASD pathophysiology 6,28 .”
From Functional impact of global rare copy number variation in autism spectrum disorders (2010) · cites this paper as [6]
In the citing paper
“loci known to exhibit incomplete penetrance and variable expressivity 6 .”
From Functional impact of global rare copy number variation in autism spectrum disorders (2010) · cites this paper as [6]
In the citing paper
“We can also expect that additional genetic/epigenetic and environmental risk factors acting at different levels of brain development could bias the phenotype toward different sets of disorders.57”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [57]
In the citing paper
“This observation is consistent with recent reports that similar copy number variants (CNVs) are found across many genomic loci in both ASD and schizophrenia (Cook and Scherer, 2008; Gejman et al., 2011; Moreno-De-Luca et al., 2010; Sanders et al., 2011).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Cook and Scherer, 2008
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Global variation in copy number in the human genome
Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler, H., Shapero, M. H., Carson, A. R., Chen, W., et al. (2006) · Nature · doi:10.1038/nature05329 · Cited by 4,288
Self-citationDetection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892 · cited 1×
“jpg" NDATA ITEM> ]> Rapid developments in microarray technologies and the discovery of extensive copy-number variation (CNV) in the human genom”
BackgroundSelf-citationGenome-wide association studies for complex traits: consensus, uncertainty and challenges
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2344 · Cited by 2,891
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795 · cited 1×
“To quantify the role of CNV in ASD, a series of studies used different microarray platforms based on oligonucleotide”
MethodLarge-scale copy number polymorphism in the human genome
Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M., et al. (2004) · Science · doi:10.1126/science.1098918 · Cited by 2,557
Structural variation in the human genome
Feuk, L., Carson, A. R., & Scherer, S. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1767 · Cited by 2,034
Self-citationα-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Advances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 1×
“For example, maternally derived duplications of chromosome 15q11–q13 confer a high risk of ASD (>85p), in contrast to paternally derived duplications whose effects can range from no effect to mild developmental and cognitive impairmen”
BackgroundStructural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815
Self-citationRare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Cited by
Items 101–200 of 664
Genomic Copy Number Variation in Disorders of Cognitive Development
Morrow, E. M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.08.009 · Cited by 121
“23 in Williams syndrome, microarrays have led to the discovery of numerous additional CNVs currently associated with intellectual disability (ID), autism, and schizophrenia.(1,2) Many of these CNVs also appear to be shared across disorders.”
Towards an evidence‐based process for the clinical interpretation of copy number variation
Riggs, E., Church, D., Hanson, K. J., Horner, V., Kaminsky, E. B., Kuhn, R. M., Wain, K., Williams, E., Aradhya, S., Kearney, H., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01818.x · Cited by 137
Schmidt‐Kastner, R., van Os, J., Esquivel, G., Steinbusch, H. W. M., & Rutten, B. P. F. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.183 · Cited by 132
Genetic and non-genetic animal models for autism spectrum disorders (ASD)
Ergaz, Z., Weinstein-Fudim, L., & Ornoy, A. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.04.024 · Cited by 107
“Region duplications are the most frequent genetic abnormality in autism— and the penetrance rate in individuals with a maternally derived duplication is >85% [39].”
BackgroundGenome‐wide Association Study of Autism Spectrum Disorder in the East Asian Populations
Liu, X., Shimada, T., Otowa, T., Wu, Y., Kawamura, Y., Tochigi, M., Iwata, Y., Umekage, T., Toyota, T., Maekawa, M., et al. (2016) · Autism Research · doi:10.1002/aur.1536 · Cited by 118
Lee, K. W., Woon, P. S., Teo, Y. Y., & Sim, K. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.09.001 · Cited by 136
Genetic Basis of Neural Tube Defects
Bassuk, A. G., & Kibar, Z. (2009) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2009.06.001 · Cited by 135
Tamada, K., Tomonaga, S., Hatanaka, F., Nakai, N., Takao, K., Miyakawa, T., Nakatani, J., & Takumi, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015126 · Cited by 117
“Although there are many candidate genes for pathophysiology in ASDs, recent high-resolution genetic techniques revealed that a de novo copy number variation (CNV) is also a significant risk factor for ASDs, and is a more important risk factor than previously recognized [4].”
BackgroundImpaired Intellect and Memory: A Missing Link Between Genetic Risk and Schizophrenia?
Toulopoulou, T., Goldberg, T. E., Mesa, I. R., Picchioni, M., Rijsdijk, F., Stahl, D., Cherny, S. S., Sham, P., Faraone, S. V., Tsuang, M., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.99 · Cited by 117
The discovery of human genetic variations and their use as disease markers: past, present and future
Ku, C., Loy, E. Y., Salim, A., Pawitan, Y., & Chia, K. S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.55 · Cited by 138
The Genetic Architecture of Schizophrenia: New Mutations and Emerging Paradigms
Rodriguez-Murillo, L., Gogos, J. A., & Karayiorgou, M. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-072010-091100 · Cited by 113
Hochstenbach, R., Buizer‐Voskamp, J. E., Vorstman, J. A. S., & Ophoff, R. A. (2011) · Cytogenetic and Genome Research · doi:10.1159/000332928 · Cited by 130
“It has been proposed that these liability variants act in an additive manner, with underlying epistatic relationships between the contributing genes [Cook and Scherer, 2008; Girirajan and Eichler, 2010; Toro et al., 2010; Poot et al., 2011].”
BackgroundGene copy number variation and common human disease
Fanciulli, M., Petretto, E. G., & Aitman, T. J. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01342.x · Cited by 140
“While heritable de novo CNVs have been associated more commonly to neuropsychiatric disorders (7), somatic CNVs that are detected, e.”
BackgroundGenome-wide association studies: a primer
Corvin, A., Craddock, N., & Sullivan, P. F. (2010) · Psychological Medicine · doi:10.1017/s0033291709991723 · Cited by 110
Copy Number Variation in Schizophrenia in the Japanese Population
Ikeda, M., Aleksić, B., Kirov, G., Kinoshita, Y., Yamanouchi, Y., Kitajima, T., Kawashima, K., Okochi, T., Kishi, T., Zaharieva, I. T., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.034 · Cited by 118
The Emerging Field of Epitranscriptomics in Neurodevelopmental and Neuronal Disorders
Angelova, M. T., Dimitrova, D. G., Dinges, N., Lence, T., Worpenberg, L., Carré, C., & Roignant, J.-Y. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00046 · Cited by 106
“Large deletions of this region underlie about 70% of cases of PWS (Peters, 2008), whereas duplication of the same region is associated with autism (Belmonte et al., 2004; Bolton et al., 2004; Cook and Scherer, 2008).”
BackgroundDo common variants play a role in risk for autism? Evidence and theoretical musings
Devlin, B., Melhem, N., & Roeder, K. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.026 · Cited by 105
“ASD and schizophrenia show some striking overlap in rare risk variants (Cook and Scherer, 2008), and it will not be too surprising to find they share some common ones as well.”
BackgroundVascular contributions to 16p11.2 deletion autism syndrome modeled in mice
Ouellette, J., Toussay, X., Comin, C. H., Costa, L. D. F., Ho, M. S. H., Lacalle‐Aurioles, M., Andrade, M. F., Liu, Q. Y., Leclerc, S., Pan, Y., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0663-1 · Cited by 108
The Cerebellar Involvement in Autism Spectrum Disorders: From the Social Brain to Mouse Models
Mapelli, L., Soda, T., D'Angelo, E. U., & Prestori, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073894 · Cited by 123
Urbanicity and Autism Spectrum Disorders
Lauritsen, M. B., Astrup, A., Pedersen, C. B., Obel, C., Schendel, D. E., Schieve, L., Yeargin-Allsopp, M., & Parner, E. T. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1875-y · Cited by 100
Ku, C., Polychronakos, C., Tan, E., Naidoo, N., Pawitan, Y., Roukos, D. H., Mort, M. E., & Cooper, D. N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.58 · Cited by 104
The Role of DNA Copy Number Variation in Schizophrenia
Tam, G. W. C., Redon, R., Carter, N. P., & Grant, S. G. N. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.027 · Cited by 98
Hydroxyurea induces de novo copy number variants in human cells
Arlt, M. F., Ozdemir, A. C., Birkeland, S. R., Wilson, T. E., & Glover, T. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109272108 · Cited by 118
Evolving Role of MeCP2 in Rett syndrome and Autism
LaSalle, J. M., & Yasui, D. H. (2009) · Epigenomics · doi:10.2217/epi.09.13 · Cited by 98
Germain, P.-L., & Testa, G. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.012 · Cited by 94
The Impact of Genetic Research on our Understanding of Normal Cognitive Ageing: 1995 to 2009
Payton, A. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9116-z · Cited by 95
“CNVs have already been associated with several neuropsychiatric conditions including schizophrenia, autism and mental retardation (Cook and Scherer 2008; Kirov et al. 2009; Kumar and Christian 2009).”
BackgroundEpigenomic strategies at the interface of genetic and environmental risk factors for autism
LaSalle, J. M. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.49 · Cited by 95
The genetic epidemiology of personality disorders
Reichborn‐Kjennerud, T. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/trkjennerud · Cited by 115
Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders
Gandhi, T., & Lee, C. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592710 · Cited by 88
Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
Davis, J. C., Dove, C. G., & Su, H. C. (2010) · Disease Markers · doi:10.1155/2010/972591 · Cited by 93
Altered Balance of Proteolytic Isoforms of Pro-Brain-Derived Neurotrophic Factor in Autism
Garcia, K. L. P., Yu, G., Nicolini, C., Michalski, B., Garzon, D. J., Chiu, V. S., Tongiorgi, E., Szatmari, P., & Fahnestock, M. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b27e4 · Cited by 92
Marker-assisted selection in plant breeding
Ben‐Ari, G., & Lavi, U. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381466-1.00011-0 · Cited by 119
The Genetics and Epigenetics of Fatigue
Landmark‐Høyvik, H., Reinertsen, K. V., Loge, J. H., Kristensen, V. N., Dumeaux, V., Fosså, S. D., Børresen‐Dale, A., & Edvardsen, H. (2010) · PM&R · doi:10.1016/j.pmrj.2010.04.003 · Cited by 98
Autism spectrum and obsessive–compulsive disorders: OC behaviors, phenotypes and genetics
Jacob, S., Landeros‐Weisenberger, A., & Leckman, J. F. (2009) · Autism Research · doi:10.1002/aur.108 · Cited by 89
Rodríguez-Santiago, B., Brunet, A., Sobrino, B., Serra-Juhé, C., Flores, R., Armengol, L., Vilella, E., Gabau, E., Guitart, M., Guillamat, R., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.53 · Cited by 88
Detection and Characterization of Copy Number Variation in Autism Spectrum Disorder
Marshall, C. R., & Scherer, S. W. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-507-7_5 · Cited by 111
Self-citationA genomic point-of-view on environmental factors influencing the human brain methylome
LaSalle, J. M. (2011) · Epigenetics · doi:10.4161/epi.6.7.16353 · Cited by 87
van Daalen, E., Kemner, C., Verbeek, N. E., van der Zwaag, B., Dijkhuizen, T., Rump, P., Houben, R., van ‘t Slot, R., de Jonge, M. V., Staal, W. G., et al. (2011) · neurogenetics · doi:10.1007/s10048-011-0297-2 · Cited by 86
“In this model, a CNV by itself may be sufficient to cause ASD or may contribute additional effect(s) to other mutation(s) such that via an additive or a synergistic interaction the threshold for full-blown ASD will be crossed [ 21 , 22].”
BackgroundMethodResultInfluentialReciprocal deletion and duplication at 2q23.1 indicates a role for MBD5 in autism spectrum disorder
Mullegama, S. V., Rosenfeld, J. A., Orellana, C., van Bon, B. W. M., Halbach, S. S., Repnikova, E. A., Brick, L., Li, C. C., Dupuis, L., Rosello, M., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.67 · Cited by 96
Fine mapping of copy number variations on two cattle genome assemblies using high density SNP array
Hou, Y., Bickhart, D. M., Hvinden, M. L., Li, C., Song, J., Boichard, D., Fritz, S., Eggen, A. A., DeNise, S. K., Wiggans, G. R., et al. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-376 · Cited by 94
“Dozens of human and mouse CNV studies have demonstrated that some CNVs are associated with phenotypic traits and diseases [9–12].”
BackgroundExome sequencing and the genetics of intellectual disability
Topper, S., Ober, C., & Das, S. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01720.x · Cited by 83
“It is likely that de novo mutations are responsible for many of these cases, as humans have a high per-generation mutation rate (54, 55) and de novo CNVs haven been shown to be causal in ∼15% of cases of intellectual disability (56, 57).”
BackgroundAnalysis of Copy Number Variation in Alzheimer’s Disease: The NIALOAD/ NCRAD Family Study
Swaminathan, S., Shen, L., Kim, S., Inlow, M., D. West, J., M. Faber, K., Foroud, T., Mayeux, R., & J. Saykin, A. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455331 · Cited by 81
“They often overlap one or more genes, and may affect gene function [16].”
Reciprocal white matter alterations due to 16p11.2 chromosomal deletions versus duplications
Chang, Y. S., Owen, J. P., Pojman, N. J., Thieu, T., Bukshpun, P., Wakahiro, M. L. J., Marco, E. J., Berman, J. I., Spiro, J. E., Chung, W. K., et al. (2016) · Human Brain Mapping · doi:10.1002/hbm.23211 · Cited by 81
Plasma cytokine levels in children with autistic disorder and unrelated siblings
Manzardo, A. M., Henkhaus, R., Dhillon, S., & Butler, M. G. (2012) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.12.003 · Cited by 81
Schulze, T. G. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.10.005 · Cited by 91
A high-resolution copy-number variation resource for clinical and population genetics
Uddin, M., Thiruvahindrapuram, B., Walker, S., Wang, Z., Hu, P., Lamoureux, S., Wei, J., MacDonald, J. R., Pellecchia, G., Lu, C., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.178 · Cited by 80
Self-citationDrug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders
Lee, H.-M., & Kim, Y. (2016) · Schizophrenia Research and Treatment · doi:10.1155/2016/6378137 · Cited by 80
“However, it may not be guaranteed whether DMLs have polypharmacological profile.”
BackgroundSwaminathan, S., Huentelman, M. J., Corneveaux, J. J., Myers, A. J., Faber, K. M., Foroud, T., Mayeux, R., Shen, L., Kim, S., Turk, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050640 · Cited by 79
“multiple genes and may affect their function [15].”
BackgroundJahshan, C., Wynn, J. K., Mathis, K. I., Altshuler, L. L., Glahn, D. C., & Green, M. F. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01008.x · Cited by 79
“There were no significant group differences in the number of acceptable deviant trials [F(2,106) = 1.”
InfluentialFunctional Impacts of NRXN1 Knockdown on Neurodevelopment in Stem Cell Models
Zeng, L., Zhang, P., Shi, L., Yamamoto, V., Lu, W., & Wang, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059685 · Cited by 79
Modeling the functional genomics of autism using human neurons
Konopka, G., Wexler, E., Rosen, E., Mukamel, Z., Osborn, G. E., Chen, L., Lu, D., Gao, F., Gao, K., Lowe, J. K., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.60 · Cited by 78
Carter, M., Nikkel, S., Fernandez, B., Marshall, C., Noor, A., Lionel, A., Prasad, A., Pinto, D., Joseph-George, A., Noakes, C., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01578.x · Cited by 77
“Other CNV or sequence-level mutations in other ASD and/or ID susceptibility genes may also contribute to the phenotype (3, 5, 15, 20).”
BackgroundSelf-citationGazzellone, M. J., Zarrei, M., Burton, C. L., Walker, S., Uddin, M., Shaheen, S. M., Coste, J., Rajendram, R., Schachter, R. J., Colasanto, M., et al. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9170-9 · Cited by 77
“Various genomic syndromes have been observed in neurodevelopmental disorders including autism, schizophrenia, and epilepsy [13].”
BackgroundSelf-citationBehavioral signatures related to genetic disorders in autism
Bruining, H., Eijkemans, M. J., Kas, M. J., Curran, S. R., Vorstman, J. A., & Bolton, P. F. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-11 · Cited by 77
“Each of the six genetic disorders has previously been shown to be associated with an increased risk of ASD [6,7,22-25].”
BackgroundCappi, C., Hounie, A. G., Mariani, D. B., Diniz, J. B., Silva, A. R. T., Reis, V. N. S., Busso, A. F., Silva, A. G., Fidalgo, F., Rogatto, S. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110198 · Cited by 77
“Although CNVs with smaller effect sizes may also have an important role in the etiology of mental disorders, their individual influences and the impact of their interaction with other CNVs on the development of mental illnesses have been poorly studied [16].”
BackgroundA novel X‐linked disorder with developmental delay and autistic features
Kaya, N., Çolak, D., AlBakheet, A., Al-Owain, M., AbuDheim, N., Al‐Younes, B., Al‐Zahrani, J., Mukaddes, N. M., Dervent, A., Aldosari, N., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22673 · Cited by 77
“While these three genomic duplication syndromes are strongly associated with autism, many other CNVs have been identified as being associated with autism, although the level of evidence and their penetrance are less dramatic.(4) We were interested in pursuing Mendelian forms of autism because these are likely to be ca…”
BackgroundModulating Neuroinflammation to Treat Neuropsychiatric Disorders
Radtke, F. A., Chapman, G., Hall, J., & Syed, Y. A. (2017) · BioMed Research International · doi:10.1155/2017/5071786 · Cited by 76
“They can also lead to frame shifts resulting in an abnormal genetic fusion product [111].”
BackgroundCoughlin, C. R., Scharer, G. H., & Shaikh, T. H. (2012) · Genome Medicine · doi:10.1186/gm381 · Cited by 89
“CNVs that involve genomic fragments containing one or more dosage-sensitive genes can result in genetic disorders and complex diseases, including autism, cancer, immune defi ciency, and neuro degenerative and neuropsychiatric disorders [2-8].”
BackgroundGenomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Smith, C., Bolton, A., & Nguyen, G. (2010) · Current Genomics · doi:10.2174/138920210793176001 · Cited by 73
Gene expression studies in autism: Moving from the genome to the transcriptome and beyond
Voineagu, I. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.017 · Cited by 72
“Several chromosomal loci have been implicated in ASD by CNV and cytogenetic studies (reviewed recently in Cook and Scherer, 2008).”
Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72
Beating the boojum: Comparative approaches to the neurobiology of social behavior
Phelps, S. M., Campbell, P., Zheng, D., & Ophir, A. G. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.043 · Cited by 75
“The availability of a densely annotated human genome, together with recent advances in sequencing and microarray technologies, have provided unprecedented insight into the molecular and neural substrates of human disorders with complex behavioral phenotypes, including autism, speech and language disorders, bipolar dis…”
Developmental anatomy of reeler mutant mouse
Katsuyama, Y., & Terashima, T. (2009) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2009.01102.x · Cited by 90
Bassett, A. S., & Costain, G. (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s21953 · Cited by 76
The impact of chromosomal microarray on clinical management: a retrospective analysis
Henderson, L. B., Applegate, C. D., Wohler, E., Sheridan, M. B., Hoover-Fong, J., & Batista, D. A. S. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.18 · Cited by 71
Argyrophilic grain disease: An underestimated tauopathy
Rodriguez, R. D., & Grinberg, L. T. (2015) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642015dn91000002 · Cited by 70
Friedman, J. M., Adam, S., Arbour, L. T., Armstrong, L., Baross, Á., Birch, P. H., Boerkoel, C. F., Chan, S. Y., Chai, D., Delaney, A. D., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-526 · Cited by 75
“It seems likely, however, that no perfect AGH platform for detection of pathogenic CNVs may ever exist and that effective clinical interpretation of these studies will continue to require considerable skill and experience [33,50,71].”
Poot, M., van der Smagt, J. J., Brilstra, E. H., & Bourgeron, T. (2011) · Cytogenetic and Genome Research · doi:10.1159/000334064 · Cited by 69
Copy Number Variable MicroRNAs in Schizophrenia and Their Neurodevelopmental Gene Targets
Warnica, W. D., Merico, D., Costain, G., Alfred, S. E., Wei, J., Marshall, C. R., Scherer, S. W., & Bassett, A. S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.011 · Cited by 72
Self-citationCognitive and Behavioral Characterization of the Potocki-Lupski Syndrome (Duplication 17p11.2)
Treadwell-Deering, D. E., Powell, M. P., & Potocki, L. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181cda67e · Cited by 68
Striano, P., Coppola, A., Paravidino, R., Malacarne, M., Gimelli, S., Robbiano, A., Traverso, M., Pezzella, M., Belcastro, V., Bianchi, A., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.1999 · Cited by 75
Amin, H., Marinaro, F., Tonelli, D. D. P., & Berdondini, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-15793-9 · Cited by 77
Jyonouchi, H., Geng, L., Streck, D. L., & Toruner, G. A. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.001 · Cited by 67
“GWAS and studies of structural variations such as CNV have provided genetic evidence of a substantial polygenetic components in ASD (Cook and Scherer, 2008; El-Fishawyand State, 2010; Rudan, 2010).”
Background16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsy
Reinthaler, E. M., Lal, D., Lebon, S., Hildebrand, M. S., Dahl, H.-H. M., Regan, B. M., Feucht, M., Steinböck, H., Neophytou, B., Ronen, G. M., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu306 · Cited by 68
Modeling human disease in rodents by CRISPR/Cas9 genome editing
Birling, M., Hérault, Y., & Pavlovic, G. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9703-x · Cited by 77
“SVs and particularly CNVs are known to be associated with neuropsychiatric diseases (Cook and Scherer 2008; Girirajan et al. 2011).”
BackgroundEndogenous retroviral genes, Herpesviruses and gender in Multiple Sclerosis
Perron, H., Bernard, C., Bertrand, J., Lang, A. B., Popa, I., Sanhadji, K., & Portoukalian, J. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.04.034 · Cited by 70
Phenotypic variations on the theme of CNVs
O’Donovan, M. C., Kirov, G., & Owen, M. J. (2008) · Nature Genetics · doi:10.1038/ng1208-1392 · Cited by 71
Copy number variation in the cattle genome
Liu, G. E., & Bickhart, D. M. (2012) · Functional & Integrative Genomics · doi:10.1007/s10142-012-0289-9 · Cited by 83
Co-expression Profiling of Autism Genes in the Mouse Brain
Menashe, I., Grange, P., Larsen, E. C., Banerjee-Basu, S., & Mitra, P. P. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003128 · Cited by 67
“Recent genomic advances have led to the discovery of diverse genetic loci linked to ASD, including chromosomal aberrations [15,16], copy number variations [11,17,18] and both common and rare single nucleotide variations (SNVs) [19–24].”
BackgroundWalsh, K. M., & Bracken, M. B. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182076c0c · Cited by 65
Genomic Copy Number Analysis in Alzheimer′s Disease and Mild Cognitive Impairment: An ADNI Study
Swaminathan, S., Kim, S., Shen, L., Risacher, S. L., Foroud, T., Pankratz, N., Potkin, S. G., Huentelman, M. J., Craig, D. W., Weiner, M. W., et al. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/729478 · Cited by 65
“CNVs have been implicated in various neuropsychiatric disorders such as autism and schizophrenia [8].”
BackgroundMouse Models of Autism: Testing Hypotheses About Molecular Mechanisms
Roullet, F., & Crawley, J. N. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_113 · Cited by 68
“Rather, a variety of de novo and familial mutations have been documented, including a large number of genetic mutations and copy number variants, each in a small number of autistic individuals (Abrahams and Geschwind 2008; Cook and Scherer 2008; Levitt and Campbell 2009; Lintas and Persico 2009).”
BackgroundMolecular Dynamics Simulations of Wild Type and Mutants of SAPAP in Complexed with Shank3
Piao, L., Chen, Z., Li, Q., Liu, R., Song, W., Kong, R., & Chang, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010224 · Cited by 68
“Indeed, the human nervous systems are highly sensitive to the dosages of these two proteins, meaning that a 50% decrease caused by a deletion/null mutation or a 50% increase due to gene duplications of Shank3 or SAPAP can cause disease [12].”
Ghani, M., Pinto, D., Lee, J. H., Grinberg, Y., Sato, C., Moreno, D., Scherer, S. W., Mayeux, R., St. George-Hyslop, P., & Rogaeva, E. (2012) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.111.000869 · Cited by 63
“Copy number variants (CNV) have been associated with several neuropsychiatric disorders, such as autism, schizophrenia, and bipolar disorder (Cook and Scherer 2008; Lee and Scherer 2010).”
Self-citationConnolly, J. J., Glessner, J. T., & Hakonarson, H. (2013) · Child Development · doi:10.1111/j.1467-8624.2012.01838.x · Cited by 62
Miyatake, S., Koshimizu, E., Fujita, A., Fukai, R., Imagawa, E., Ohba, C., Kuki, I., Nukui, M., Araki, A., Makita, Y., et al. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2014.124 · Cited by 63
Female Autism Phenotypes Investigated at Different Levels of Language and Developmental Abilities
Howe, Y. J., O’Rourke, J. A., Yatchmink, Y., Viscidi, E. W., Jones, R. N., & Morrow, E. M. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-015-2501-y · Cited by 62
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
“Maternally inherited duplications at 15q11-13 (#MIN608636) is one of the most frequent and penetrant copy number variation in ASD, found in ~1%–2% of patients [237,238], suggesting that one or several genes from this region, when duplicated, can lead to ASD.”
BackgroundKalkman, H. O. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.11.002 · Cited by 60
“These variations can be duplications or insertional transpositions, but also copy-number losses (by deletions) (for review see Cook & Scherer, 2008).”
BackgroundMeguro-Horike, M., Yasui, D. H., Powell, W., Schroeder, D. I., Oshimura, M., LaSalle, J. M., & Horike, S.-I. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr298 · Cited by 59
“BAC clones for FISH are as follow; RP11-69H14 (CYFIP1), RP11-373J1 (NDN), RP11-125E1 (SNRPN), RP11-171C8 (HBII-85), RP11-1081A4 (UBE3A), RP11-339C21 (ATP10A), RP11-92F7 (TJP1), RP11-714E8 (CHRNA7), RP11-638J6 (GABRB3(1)), RP11-345N11 (GABRB3(2)), RP11-974L14 (GABRB3(3)), RP11-243J20 (GABRA5), RP11-89E18 (GABRG3), RP11…”
BackgroundSagar, A., Bishop, J. R., Tessman, D. C., Guter, S. J., Martin, C. L., & Cook, E. H. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35754 · Cited by 63
“Multiple rare de novo copy number variants (CNVs) contribute to genetic vulnerability to autism and schizophrenia [Cook and Scherer, 2008].”
Rare CNVs and Tag SNPs at 15q11.2 are associated with schizophrenia in the Han Chinese population
Zhao, Q., Li, T., Zhao, X., Huang, K., Wang, T., Li, Z., Ji, J., Zeng, Z., Zhang, Z., Li, K., et al. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr197 · Cited by 58
Crabtree, G. R. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.10.002 · Cited by 64
Genomic architecture of human neuroanatomical diversity
Toro, R., Poline, J., Huguet, G., Loth, E., Frouin, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Carvalho, F. M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.99 · Cited by 59
Yi, H.-C., You, Z., Wang, M.-N., Guo, Z.-H., Wang, Y., & Zhou, J.-R. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3406-0 · Cited by 64
Alaerts, M., & Del‐Favero, J. (2009) · Human Mutation · doi:10.1002/humu.21042 · Cited by 65
“…peripheral neuropathy, or specific syndromes that include neurological symptoms such as mental retardation, psychiatric symptoms, or cognitive deficits, a causal relationship with specific CNVs or structural variants has been established [reviewed in Lee and Lupski, 2006; Cook and Scherer, 2008].”
BackgroundArlt, M. F., Rajendran, S., Birkeland, S. R., Wilson, T. E., & Glover, T. W. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002981 · Cited by 56
“Normal polymorphic CNVs are a major contributor to human genomic variation and phenotypic diversity [2,3,4,5,6], while spontaneous CNVs are a very important and frequent cause of genetic and developmental disorders, including intellectual disability, neuropsychiatric disorders, and structural birth defects [7,8,9,10,1…”
BackgroundGadow, K. D., DeVincent, C. J., Olvet, D. M., Pisarevskaya, V., & Hatchwell, E. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07382.x · Cited by 55
“We do know, however, that both common (Flint & Mackay, 2009) and rare (Cook & Scherer, 2008) gene variants are often associated with multiple and fairly diverse clinical traits.”
BackgroundIrvin, M. R., Wineinger, N. E., Rice, T. K., Pajewski, N. M., Kabagambe, E. K., Gu, C. C., Pankow, J., North, K. E., Wilk, J. B., Freedman, B. I., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024052 · Cited by 55
“additional genetic variability associated with complex human traits [12,13].”
BackgroundMixed Sequence Reader: A Program for Analyzing DNA Sequences with Heterozygous Base Calling
Chang, C.-T., Tsai, C., Tang, C. Y., Chen, C., Lian, J.-H., Hu, C.-Y., Tsai, C.-L., Chao, A., Lai, C., Wang, T., et al. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/365104 · Cited by 63
“For instance, CNVs in DEFB4 are associated with susceptibility to infectious disease, autoimmune, inflammatory disorders, and even cancers [5, 20].”
Background
Metadata
- Authors
- Cook Jr, E. H., & Scherer, S. W.
- Affiliations
- University of Toronto (CA)
- ORCID
- Scherer, Stephen W.
- Venue
- Nature
- Published
- 2008-10
- Volume
- 455
- Issue
- 7215
- Pages
- 919-923
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2074579392
- Cited by
- 659
- References
- 53
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 10 · 2023: 16 · 2022: 7 · 2021: 32 · 2020: 12 · 2019: 22 · 2018: 17 · 2017: 32 · 2016: 27 · 2015: 41 · 2014: 57 · 2013: 49 · 2012: 82
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD055751, HD055751)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genome Rearrangement Algorithms
- Keywords
- copy number variation, neuropsychiatric disorders, autism spectrum disorder, schizophrenia, genetic susceptibility, disease-associated genes, microarray genotyping
- MeSH terms
- Animals, Autistic Disorder, Mental Disorders, Humans, Nervous System Diseases, Schizophrenia, Gene Dosage, Genetic Predisposition to Disease, Genomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.